Literature DB >> 19013300

Leucine, when ingested with glucose, synergistically stimulates insulin secretion and lowers blood glucose.

Dionysia Kalogeropoulou1, Laura Lafave, Kelly Schweim, Mary C Gannon, Frank Q Nuttall.   

Abstract

Our laboratory is interested in the metabolic effects of ingested proteins. As part of this research, we currently are investigating the metabolic effects of ingested individual amino acids. The objective of the current study was to determine whether leucine stimulates insulin and/or glucagon secretion and whether, when it is ingested with glucose, it modifies the glucose, insulin, or glucagon response. Thirteen healthy subjects (6 men and 7 women) were studied on 4 different occasions. Subjects were admitted to the special diagnostic and treatment unit after a 12-hour fast. They received test meals at 8:00 am. On the first occasion, they received water only. Thereafter, they received 25 g glucose or 1 mmol/kg lean body mass leucine or 1 mmol/kg lean body mass leucine plus 25 g glucose in random order. Serum leucine, glucose, insulin, glucagon, and alpha-amino nitrogen concentrations were measured at various times during a 2.5-hour period after ingestion of the test meal. The amount of leucine provided was equivalent to that present in a high-protein meal, that is, that approximately present in a 350-g steak. After leucine ingestion, the leucine concentration increased 7-fold; and the alpha-amino nitrogen concentration increased by 16%. Ingested leucine did not affect the serum glucose concentration. When leucine was ingested with glucose, it reduced the 2.5-hour glucose area response by 50%. Leucine, when ingested alone, increased the serum insulin area response modestly. However, it increased the insulin area response to glucose by an additional 66%; that is, it almost doubled the response. Ingested leucine stimulated an increase in glucagon. Ingested glucose decreased it. When ingested together, the net effect was essentially no change in glucagon area. In summary, leucine at a dose equivalent to that present in a high-protein meal, had little effect on serum glucose or insulin concentrations but did increase the glucagon concentration. When leucine was ingested with glucose, it attenuated the serum glucose response and strongly stimulated additional insulin secretion. Leucine also attenuated the decrease in glucagon expected when glucose alone is ingested. The data suggest that a rise in glucose concentration is necessary for leucine to stimulate significant insulin secretion. This in turn reduces the glucose response to ingested glucose.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19013300     DOI: 10.1016/j.metabol.2008.09.001

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  32 in total

Review 1.  Leucine metabolism in regulation of insulin secretion from pancreatic beta cells.

Authors:  Jichun Yang; Yujing Chi; Brant R Burkhardt; Youfei Guan; Bryan A Wolf
Journal:  Nutr Rev       Date:  2010-05       Impact factor: 7.110

2.  Leucine stimulates insulin secretion via down-regulation of surface expression of adrenergic α2A receptor through the mTOR (mammalian target of rapamycin) pathway: implication in new-onset diabetes in renal transplantation.

Authors:  Jun Yang; Michael Dolinger; Gabrielle Ritaccio; Joseph Mazurkiewicz; David Conti; Xinjun Zhu; Yunfei Huang
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

Review 3.  Physiological effects of nutrients on insulin release by pancreatic beta cells.

Authors:  Monica Losada-Barragán
Journal:  Mol Cell Biochem       Date:  2021-04-12       Impact factor: 3.396

4.  Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome.

Authors:  Alice Y Chang; Antigoni Z Lalia; Gregory D Jenkins; Tumpa Dutta; Rickey E Carter; Ravinder J Singh; K Sreekumaran Nair
Journal:  Metabolism       Date:  2017-03-08       Impact factor: 8.694

5.  The metabolite profiles of the obese population are gender-dependent.

Authors:  Guoxiang Xie; Xiaojing Ma; Aihua Zhao; Congrong Wang; Yinan Zhang; David Nieman; Jeremy K Nicholson; Wei Jia; Yuqian Bao; Weiping Jia
Journal:  J Proteome Res       Date:  2014-08-26       Impact factor: 4.466

6.  Decreased serum essential and aromatic amino acids in patients with chronic pancreatitis.

Authors:  Krystian Adrych; Marian Smoczynski; Magdalena Stojek; Tomasz Sledzinski; Ewa Slominska; Elzbieta Goyke; Ryszard-Tomasz Smolenski; Julian Swierczynski
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

7.  Very low carbohydrate diet significantly alters the serum metabolic profiles in obese subjects.

Authors:  Yunjuan Gu; Aihua Zhao; Fengjie Huang; Yinan Zhang; Jiajian Liu; Congrong Wang; Wei Jia; Guoxiang Xie; Weiping Jia
Journal:  J Proteome Res       Date:  2013-11-18       Impact factor: 4.466

8.  Mutations in TBCK, Encoding TBC1-Domain-Containing Kinase, Lead to a Recognizable Syndrome of Intellectual Disability and Hypotonia.

Authors:  Elizabeth J Bhoj; Dong Li; Margaret Harr; Shimon Edvardson; Orly Elpeleg; Elizabeth Chisholm; Jane Juusola; Ganka Douglas; Maria J Guillen Sacoto; Karine Siquier-Pernet; Abdelkrim Saadi; Christine Bole-Feysot; Patrick Nitschke; Alekhya Narravula; Maria Walke; Michele B Horner; Debra-Lynn Day-Salvatore; Parul Jayakar; Samantha A Schrier Vergano; Mark A Tarnopolsky; Madhuri Hegde; Laurence Colleaux; Peter Crino; Hakon Hakonarson
Journal:  Am J Hum Genet       Date:  2016-03-31       Impact factor: 11.025

9.  Protein hydrolysates in sports nutrition.

Authors:  Anssi H Manninen
Journal:  Nutr Metab (Lond)       Date:  2009-09-28       Impact factor: 4.169

10.  5q35 duplication presents with psychiatric and undergrowth phenotypes mediated by NSD1 overexpression and mTOR signaling downregulation.

Authors:  Fabiola Quintero-Rivera; Celeste C Eno; Christine Sutanto; Kelly L Jones; Małgorzata J M Nowaczyk; Derek Wong; Dawn Earl; Ghayda Mirzaa; Anita Beck; Julian A Martinez-Agosto
Journal:  Hum Genet       Date:  2021-01-03       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.